Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2798

1.

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S, Bastert G.

J Natl Cancer Inst. 1996 Nov 20;88(22):1652-8.

PMID:
8931609
2.

The importance of extracapsular extension of axillary lymph node metastases in breast cancer.

Ilknur GB, Hilmi A, Tülay C, Oguz C, Selma S, Serdar S, Uğur Y, Pinar B, Omer H, Münir K; Dokuz Eylül University Medical Faculty Breast Tumors Study Group.

Tumori. 2004 Jan-Feb;90(1):107-11.

PMID:
15143982
3.

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S.

J Natl Cancer Inst. 1996 Dec 4;88(23):1764-9.

PMID:
8944007
4.

Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.

Sosa JA, Diener-West M, Gusev Y, Choti MA, Lange JR, Dooley WC, Zeiger MA.

Ann Surg Oncol. 1998 Mar;5(2):140-9.

PMID:
9527267
5.

Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.

Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.

Jpn J Clin Oncol. 2005 Mar;35(3):126-33.

PMID:
15741302
6.

Prognostic analysis of survival in small breast cancers.

Mustafa IA, Cole B, Wanebo HJ, Bland KI, Chang HR.

J Am Coll Surg. 1998 May;186(5):562-9.

PMID:
9583697
7.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
8.

Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.

Solomayer EF, Diel IJ, Salanti G, Hahn M, Gollan C, Schütz F, Bastert G.

Clin Cancer Res. 2001 Dec;7(12):4102-8.

9.

Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.

Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ.

J Natl Cancer Inst. 1996 Nov 20;88(22):1659-64.

PMID:
8931610
10.

Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.

Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki JR.

J Natl Cancer Inst. 2005 Dec 21;97(24):1840-7.

PMID:
16368946
11.

Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.

Meric F, Mirza NQ, Buzdar AU, Hunt KK, Ames FC, Ross MI, Pollock RE, Newman LA, Feig BW, Strom EA, Buchholz TA, McNeese MD, Hortobagyi GN, Singletary SE.

Ann Surg Oncol. 2000 Jul;7(6):435-40.

PMID:
10894139
12.

Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.

Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):883-94.

PMID:
10863056
13.

Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.

Diel IJ, Cote RJ.

Cancer Treat Rev. 2000 Feb;26(1):53-65. Review.

PMID:
10660491
14.

Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?

Rack B, Janni W, Gerber B, Strobl B, Schindlbeck C, Klanner E, Rammel G, Sommer H, Dimpfl T, Friese K.

Breast Cancer Res Treat. 2003 Nov;82(2):83-92.

PMID:
14692652
15.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
16.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
17.

Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.

Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, Vicini FA.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):658-70.

PMID:
12788171
18.

Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.

Gebauer G, Fehm T, Merkle E, Jaeger W, Mitze M.

Anticancer Res. 2003 Sep-Oct;23(5b):4319-24.

PMID:
14666645
19.

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.

Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP.

J Am Coll Surg. 2000 Jul;191(1):1-6; discussion 6-8.

PMID:
10898177
20.

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H, Tominaga T.

J Natl Cancer Inst. 1997 Jan 15;89(2):139-47.

PMID:
8998183

Supplemental Content

Support Center